Hasnyálmirigyrák: vizsgálatok itt: Kína
326 trials · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleBelzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
- Where
- Beijing, Chengdu, Guangzhou, Shanghai
- Életkor
- 12 év and over
- People
- 355 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT04924075 · EU 2023-504853-11-00 - No phaseNot yet taking people in KínaA Multicenter, Prospective Single-arm Study of Multimodal Thermal Therapy Combined With Toripalimab and AG Chemotherapy in the Treatment of Advanced Pancreatic Cancer
- Where
- Chengdu, Qingdao, Shanghai, Xi'an
- Életkor
- 18 év to 75 év
- People
- 56
- Run by
- Ruijin Hospital
See details and how to joinNCT07928362 - 1/2. fázisTaking peopleGnP Combined With SHR-1701 and Apatinib as First-Line Treatment for Metastatic PDAC
- Where
- Chengdu
- Életkor
- 18 év to 75 év
- People
- 45
- Run by
- West China Hospital
See details and how to joinNCT07802184 - No phaseTaking peopleArtificial Intelligence-Assisted 4D Dynamic Long-Axial PET Imaging for the Detection of Early Pancreatic Cancer Lesions
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 50
- Run by
- Ruijin Hospital
See details and how to joinNCT07925125 - 2. fázisCsak meghívásosA Single-Arm Study of Nimotuzumab Combined With NALIRIFOX as First-Line Treatment for Pancreatic Cancer
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 45
- Run by
- Fudan University
See details and how to joinNCT07920731 - 1. fázisTaking peopleA Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
- Where
- Changsha
- Életkor
- 18 év and over
- People
- 540 worldwide
- Run by
- Pfizer
See details and how to joinNCT07090499 · EU 2025-521729-33-00 - No phaseNot yet taking people in KínaAI-Assisted Differentiation of Pancreatic Cystic Lesions Using EUS Images and Clinical Features
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 400
- Run by
- Ruijin Hospital
See details and how to joinNCT07919704 - 1. fázisTaking peopleA Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- Where
- Beijing, Guangzhou, Shanghai
- Életkor
- 18 év and over
- People
- 460 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06465069 · EU 2024-512927-36-00 - 2. fázisTaking peopleA Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- Where
- Beijing, Changsha, Hangzhou, Shanghai
- Életkor
- 18 év and over
- People
- 111 worldwide
- Run by
- Bayer
See details and how to joinNCT06760819 · EU 2024-517419-62-00 - 1. fázisTaking peopleA Study of LY4337713 in Participants With FAP-Positive Solid Tumors
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 340 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07213791 · EU 2025-521887-37-00 - 2. fázisTaking peopleA Study of Navlimetostat (BMS-986504) Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
- Where
- Beijing, Chongqing, Guangzhou, Shanghai, Xinxiang
- Életkor
- 18 év and over
- People
- 254 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07492680 - 1/2. fázisTaking peopleA Study of GKL-006 Injection in Patients With Advanced Pancreatic Cancer
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 52
- Run by
- Beijing Gene Key Life Technology Co., Ltd
See details and how to joinNCT07777211 - 3. fázisTaking peopleA Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
- Where
- Guangzhou, Shanghai
- Életkor
- 18 év and over
- People
- 614 worldwide
- Run by
- Astellas Pharma Global Development, Inc.
See details and how to joinNCT07409272 · EU 2025-523684-38-00 - 2/3. fázisTaking peopleZanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
- Where
- Hong Kong
- Életkor
- 18 év and over
- People
- 440 worldwide
- Run by
- Exelixis
See details and how to joinNCT06943755 · EU 2025-521043-20-00 - 1/2. fázisTaking peopleA Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
- Where
- Beijing, Changsha, Chengdu, Fuzhou, Shanghai, Wuhan
- Életkor
- 18 év and over
- People
- 220 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06428409 · EU 2023-508703-21-00 - 1/2. fázisTaking peopleA Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
- Where
- Beijing, Hangzhou, Nanjing, Wuhan
- Életkor
- 18 év and over
- People
- 450 worldwide
- Run by
- Bayer
See details and how to joinNCT06914128 · EU 2025-520623-24-00 - 3. fázisNot yet taking people in KínaHRS-4642 Combined With Antitumor Agents for the Treatment of Perioperative Pancreatic Cancer
- Where
- Beijing, Shanghai
- Életkor
- 18 év to 75 év
- People
- 825
- Run by
- Shanghai Hengrui Pharmaceutical Co., Ltd.
See details and how to joinNCT07900789 - 2. fázisTaking peopleA Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Where
- Chengdu, Guangzhou
- Életkor
- 18 év and over
- People
- 740 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06172478 · EU 2023-507641-29-00 - 3. fázisTaking peopleHRS 4642 Injection Combined With AG Versus Placebo Combined With AG Therapy in First-Line Advanced or Metastatic Pancreatic Cancer
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 588
- Run by
- Jiangsu HengRui Medicine Co., Ltd.
See details and how to joinNCT07232875 - 1/2. fázisTaking peopleAn Open-Label, Multicenter, Phase IB/II Clinical Study of HRS-7172 in Combination With Antitumor Therapy in Participants With Solid Tumors
- Where
- Shanghai
- Életkor
- 18 év to 70 év
- People
- 140
- Run by
- Jiangsu HengRui Medicine Co., Ltd.
See details and how to joinNCT07806058 - No phaseTaking peopleBecotatug Vedotin Plus Anti-PD-1 and S-1 in Patients With EGFR-Positive Advanced Pancreatic Cancer Who Have Failed at Least One Line of Standard Therapy
- Where
- Ningbo
- Életkor
- 18 év to 85 év
- People
- 27
- Run by
- Ningbo Medical Center Lihuili Hospital
See details and how to joinNCT07892573 - 1. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of CT041 After Adjuvant Chemotherapy for Pancreatic Cancer
- Where
- Beijing, Changsha, Hangzhou, Shanghai, Wuhan, Xian, Zhengzhou
- Életkor
- 18 év to 79 év
- People
- 20
- Run by
- CARsgen Therapeutics Co., Ltd.
See details and how to joinNCT05911217 - 2. fázisTaking peopleSintilimab Combined With Chemotherapy and Radiotherapy in Patients With Inoperable Pancreatic Cancer
- Where
- Jinan
- Életkor
- 18 év to 75 év
- People
- 25
- Run by
- Shandong Cancer Hospital and Institute
See details and how to joinNCT06050317 - No phaseTaking people68Ga-SorB PET/CT Imaging in Patients With Solid Tumors
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 50
- Run by
- Peking University Third Hospital
See details and how to joinNCT07760012 - 2. fázisNot yet taking people in KínaIntestinal Low-Dose Radiotherapy Combined With Immune Checkpoint Inhibitors in Solid Tumors With Liver Metastases
- Where
- Hangzhou
- Életkor
- 18 év and over
- People
- 120
- Run by
- Bing Xia
See details and how to joinNCT07875465